This article relies largely or entirely on a single source. (July 2019) |
| Clinical data | |
|---|---|
| Other names | 2-Ethoxy-4,5-dimethoxyamphetamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID |
|
| ChemSpider | |
| UNII |
|
| CompTox Dashboard (EPA) |
|
| Chemical and physical data | |
| Formula | C13H21NO3 |
| Molar mass | 239.315 g·mol−1 |
| 3D model (JSmol) |
|
| |
| (verify) | |
EMM, also known as 2-ethoxy-4,5-dimethoxyamphetamine, is a substituted amphetamine.[1] It is a dimethoxy-ethoxy analogue of trimethoxyamphetamine (TMA-2).[1] EMM was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, both the dose and duration are unknown.[1] EMM produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of EMM.[1]
See also
References
- ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. EMM Entry in PiHKAL